Leigh Baldwin & Co’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
1,463
-111
-7% -$16.5K 0.13% 161
2026
Q1
$231K Sell
1,574
-234
-13% -$36.1K 0.15% 143
2025
Q4
$280K Sell
1,808
-324
-15% -$48.5K 0.18% 123
2025
Q3
$297K Sell
2,132
-356
-14% -$48.2K 0.17% 144
2025
Q2
$335K Sell
2,488
-77
-3% -$10.4K 0.22% 116
2025
Q1
$375K Buy
2,565
+502
+24% +$72.9K 0.3% 95
2024
Q4
$284K Buy
+2,063
New +$302K 0.24% 121

Other funds holding XLV

Leigh Baldwin & Co's XLV Position: Q2 2026 in Review

Leigh Baldwin & Co reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 7.1% in Q2 2026, selling an estimated $16.5K and leaving 1,463 shares worth $232K. The position accounts for 0.13% of the portfolio, ranked #161.

Leigh Baldwin & Co first reported a position in XLV in Q4 2024 and has held it in 7 quarters since. The position peaked at $375K in Q1 2025. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Leigh Baldwin & Co held 1,463 shares of State Street Health Care Select Sector SPDR ETF worth $232K as of Q2 2026.
  • Leigh Baldwin & Co sold 111 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $16.5K.
  • State Street Health Care Select Sector SPDR ETF made up 0.13% of Leigh Baldwin & Co's portfolio in Q2 2026, its #161 holding.
  • Leigh Baldwin & Co first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's State Street Health Care Select Sector SPDR ETF position peaked at $375K in Q1 2025.
  • 1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.